You are here

Study Of Fesoterodine In Pediatric Overactive Bladder Patients Aged 8-17 Years

Last updated on March 11, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Little Rock, Arkansas, 72204 United States
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Overactive Bladder, Neurogenic Detrusor Overactivity
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
8-17 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- A total body weight >25 kg (55 lbs).

- Symptoms of urinary frequency (average ≥8 daily bathroom visits to urinate) and
urgency to urinate, with or without urgency incontinence, for at least 6 months prior
to enrolment, OR

- Stable neurological disease and urodynamically confirmed detrusor overactivity, who
may require intermittent catheterization for management of urinary drainage.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Treatment with an investigational drug within 4 weeks or 5 half-lives, whichever is
longer, before first study dose

- Ongoing use of potent CYP3A4 inhibitors or inducers or CYP2D6 inhibitors

- Ongoing use of another drug for treating overactive bladder

- Uncontrolled narrow angle glaucoma, urinary or gastric retention

NCT00857896
Pfizer
Completed
Study Of Fesoterodine In Pediatric Overactive Bladder Patients Aged 8-17 Years

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now